|
SOCS4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.81450418526674E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.14349996138685E-09 |
| Normal-vs-Stage2 |
2.580100E-03 |
| Normal-vs-Stage3 |
3.93090004990881E-10 |
| Normal-vs-Stage4 |
3.90820709128548E-12 |
| Stage1-vs-Stage2 |
1.131630E-01 |
| Stage1-vs-Stage3 |
4.000000E-02 |
| Stage1-vs-Stage4 |
8.24799999999959E-05 |
| Stage2-vs-Stage3 |
9.341900E-03 |
| Stage2-vs-Stage4 |
1.621310E-04 |
| Stage3-vs-Stage4 |
7.250100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95670146752036E-11 |
| Normal-vs-AfricanAmerican |
8.636300E-04 |
| Normal-vs-Asian |
1.29629999956471E-07 |
| Caucasian-vs-AfricanAmerican |
6.481000E-01 |
| Caucasian-vs-Asian |
6.842200E-01 |
| AfricanAmerican-vs-Asian |
5.101600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40699996098448E-09 |
| Normal-vs-Female |
2.03720040836686E-10 |
| Male-vs-Female |
3.357600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50750000260658E-08 |
| Normal-vs-Age(41-60Yrs) |
3.73860054025954E-10 |
| Normal-vs-Age(61-80Yrs) |
6.12049999570985E-09 |
| Normal-vs-Age(81-100Yrs) |
7.488300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.891830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.541200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.767800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.934600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.558000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.482000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.74810000000459E-05 |
| Classical-VS-Follicular |
5.791400E-01 |
| Classical-VS-Other |
2.191800E-01 |
| Classical-VS-Normal |
1.39360001316646E-09 |
| Tall-VS-Follicular |
2.644300E-04 |
| Tall-VS-Other |
6.361400E-01 |
| Tall-VS-Normal |
1.13720144412355E-11 |
| Follicular-VS-Other |
2.204400E-01 |
| Follicular-VS-Normal |
2.22299999999009E-05 |
| Other-VS-Normal |
1.581200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11240000544299E-08 |
| Normal-vs-N1 |
4.92219998093901E-09 |
| N0-vs-N1 |
1.144000E-01 |
|
|
